HIV P24 monoclonal antibodies, 8/17

August 2017—Binding Site’s Immunologicals Group has added a number of monoclonal antibodies used for the clinical testing of human immunodeficiency virus to its line of in vitro diagnostic manufacturing and clinical research applications. The HIV P24 275, HIV P24 114, and HIV P24 9.23.11.8.9.4 anti-human monoclonal antibodies have been designed for use as an integral component within a number of enzyme immunoassay testing procedures.

All of the novel monoclonal antibodies are sourced from mice and processed using various chromatographic techniques to a purity level of greater than 95 percent. Matched antibody pairs are available (coater/tracer), which greatly aid in product and application development, according to the company. The antibodies are supplied preservative free, demonstrate lot-to-lot consistency, and have a shelf-life stability of four years from date of manufacture. The products are available in a standard 1.0 mg fill vial, with larger, bulk configurations also available.

Binding Site, 800-633-4484